Cargando…
Therapies for Tau-associated neurodegenerative disorders: targeting molecules, synapses, and cells
Advances in experimental and computational technologies continue to grow rapidly to provide novel avenues for the treatment of neurodegenerative disorders. Despite this, there remain only a handful of drugs that have shown success in late-stage clinical trials for Tau-associated neurodegenerative di...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358644/ https://www.ncbi.nlm.nih.gov/pubmed/37449601 http://dx.doi.org/10.4103/1673-5374.373670 |